56-45 Main Street, Flushing, NY, 11355 · (718) 670-2000
Beds
492
FY 2025
Star rating
5 of 5
Patient survey: 3 of 5
Net patient revenue
$1.15B
FY 2025
Net income
$126.3M
Patient care margin -103.6%
Discharges
26,484
Occupancy 87.5%
Clinicians
701
From the hospital's yearly cost reports (fiscal years as the hospital reports them)
Locations are shown at the center of the ZIP code.
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2025 | $1.15B | $2.35B | -103.6% | $126.3M | 26,484 | $22.2M | 24.4% | 7.3% |
Official hospital quality measures with the national median across hospitals. For ratios, 1.00 means as many cases as expected.
| Death rate for COPD patients | 6.1% | US median 8.5% |
| Death rate for heart attack patients | 10.7% | US median 11.8% |
| Death rate for heart failure patients | 6.9% | US median 11% |
| Hospital-wide death rate within 30 days | 2.4% | US median 3.9% |
| Death rate for pneumonia patients | 12.8% | US median 15.2% |
| Death rate for stroke patients | 8.8% | US median 11.6% |
Medicare clinicians who list this hospital, by specialty
Inpatient stays by diagnosis related group (DRG), 2024
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.
Medicare clinicians who work here
| 2024 | $1.10B | $1.96B | -78.1% | -$7.9M | 27,028 | $23.7M | 25.0% | 6.3% |
| 2023 | $1.01B | $1.69B | -67.7% | $39.4M | 25,744 | $12.7M | 25.8% | 6.6% |
| 2022 | $890.1M | $1.41B | -58.7% | -$58.6M | 24,884 | $12.7M | 26.7% | 6.9% |
| 2021 | $879.3M | $1.24B | -40.6% | $69.3M | 26,758 | $10.3M | 24.7% | 7.1% |
| 2020 | $798.6M | $1.12B | -40.6% | -$23.0M | 25,529 | $13.7M | 26.4% | 8.9% |
| Readmission rate after heart bypass surgery | 9.8% | US median 10.9% |
| Readmission rate for COPD | 20.3% | US median 19.8% |
| Readmission rate after a heart attack | 13.7% | US median 14.4% |
| Readmission rate for heart failure | 19.2% | US median 21.3% |
| Readmission rate after hip or knee replacement | 3.5% | US median 5.8% |
| Readmission rate for pneumonia | 16.8% | US median 17.2% |
| Complications after hip or knee replacement | 2% | US median 4.1% |
| Serious complications (patient safety composite) | 0.62 | US median 0.96 · better |
| C. diff intestinal infections (ratio to expected) | 0.08 | US median 0.28 · better |
| Central line bloodstream infections (ratio to expected) | 0.00 | US median 0.48 · better |
| Surgical site infections after colon surgery (ratio to expected) | 0.50 | US median 0.72 |
| MRSA bloodstream infections (ratio to expected) | 0.67 | US median 0.60 |
| Catheter urinary tract infections (ratio to expected) | 0.35 | US median 0.40 · better |
| Doctors always communicated well | 76% | US median 79% |
| Nurses always communicated well | 71% | US median 80% |
| Patient survey summary star rating | 3 of 5 | US median 3 of 5 |
| Area around the room always quiet at night | 51% | US median 59% |
| Patients who rated the hospital 9 or 10 out of 10 | 64% | US median 72% |
| Room and bathroom always clean | 69% | US median 73% |
| Patients who would definitely recommend the hospital | 67% | US median 71% |
| Patients who left the emergency department before being seen | 6% | US median 1% |
| Median time in the emergency department before leaving (minutes) | 280 min | US median 148 min |
| Patients prescribed 2 or more opioids or opioids with benzodiazepines at discharge | 8% | US median 15% |
| Patients who got appropriate care for severe sepsis and septic shock | 92% | US median 65% |
| Healthcare workers given the flu vaccine | 94% | US median 79% |
| 129 |
| $122,882.18 |
| $17,002.82 |
| $12,667.88 |
| DRG 470 MAJOR HIP AND KNEE JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MCC | 124 | $74,243.44 | $17,979.95 | $14,289.25 |
| DRG 870 SEPTICEMIA OR SEVERE SEPSIS WITH MV >96 HOURS | 118 | $376,765.95 | $70,875.16 | $58,777.93 |
| DRG 689 KIDNEY AND URINARY TRACT INFECTIONS WITH MCC | 118 | $86,529.06 | $11,442.86 | $8,838.11 |
| DRG 193 SIMPLE PNEUMONIA AND PLEURISY WITH MCC | 114 | $113,188.59 | $13,095.16 | $9,867.73 |
| DRG 312 SYNCOPE AND COLLAPSE | 102 | $63,466.90 | $8,170.34 | $6,636.32 |
| DRG 853 INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITH MCC | 100 | $323,468.52 | $52,372.69 | $40,556.82 |
| DRG 872 SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MCC | 95 | $71,083.97 | $9,474.98 | $7,681.44 |
| DRG 690 KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MCC | 82 | $62,996.33 | $7,752.73 | $5,985.69 |
| DRG 698 OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MCC | 75 | $139,557.48 | $17,983.25 | $13,076.55 |
| DRG 064 INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MCC | 72 | $155,582.79 | $20,188.71 | $15,695.20 |
| DRG 683 RENAL FAILURE WITH CC | 70 | $64,513.47 | $8,647.83 | $6,629.69 |
| DRG 640 MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITH MCC | 66 | $82,288.89 | $12,422.42 | $10,642.23 |
Hospital outpatient services by payment group (APC), 2024
| Service group | Services | Patients | Medicare pays per service | All hospitals |
|---|---|---|---|---|
| APC 5072 Level 2 Excision/ Biopsy/ Incision and Drainage | 122 | 112 | $1,437.64 | $1,219.56 |
| APC 5191 Level 1 Endovascular Procedures | 101 | 101 | $2,636.59 | $2,207.96 |
| APC 5114 Level 4 Musculoskeletal Procedures | 93 | 88 | $6,506.04 | $5,338.75 |
| APC 5374 Level 4 Urology and Related Services | 90 | 76 | $3,088.35 | $2,629.24 |
| APC 5302 Level 2 Upper GI Procedures | 78 | 73 | $1,707.19 | $1,444.50 |
| APC 5491 Level 1 Intraocular Procedures | 75 | 51 | $2,112.78 | $1,751.67 |
| APC 5213 Level 3 Electrophysiologic Procedures | 73 | 72 | $25,315.65 | $21,117.37 |
| APC 5112 Level 2 Musculoskeletal Procedures | 69 | 65 | $1,453.03 | $1,196.16 |
| APC 5375 Level 5 Urology and Related Services | 65 | 60 | $4,691.25 | $3,917.51 |
| APC 5361 Level 1 Laparoscopy and Related Services | 60 | 60 | $5,144.07 | $4,357.80 |
| APC 5193 Level 3 Endovascular Procedures | 56 | 51 | $10,864.44 | $8,873.86 |
| APC 5373 Level 3 Urology and Related Services | 51 | 41 | $1,754.83 | $1,516.28 |
Reported payments to this teaching hospital
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 3 | $164K |
| Janssen Research & Development, LLC JNJ | 13 | $56K |
| Novartis Pharmaceuticals Corporation NVS | 5 | $29K |
| Boston Scientific Corporation BSX | 4 | $28K |
| Endotronix, Inc. | 1 | $17K |
| Siemens Medical Solutions USA, Inc. SHL.DE | 2 | $14K |
| Humacyte Global, Inc. | 3 | $5,617 |
| Stryker Corporation SYK | 5 | $4,436 |
| Volta Medical Inc | 1 | $4,250 |
| Suvon Surgical LLC | 1 | $3,000 |
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
New York-Presbyterian/Queens is a nonprofit short-term acute care hospital in Flushing, NY with 492 beds, part of New York Presbyterian Healthcare System and a 5-star overall rating.
New York-Presbyterian/Queens in Flushing, NY has 492 beds (fiscal year 2025 cost report); 535 beds are certified for Medicare. It discharged 26,484 inpatients that year, with 87.5% of its beds in use on average.
In fiscal year 2025 (ending 2025-12-31), New York-Presbyterian/Queens reported net patient revenue of $1.15B and operating expenses of $2.35B, a margin on patient care of -103.6%. After other income and expenses its net income was $126.3M (5.4% of revenue), so it made a profit that year.
New York-Presbyterian/Queens is part of New York Presbyterian Healthcare System, a health system with 4 hospitals based in New York, NY. It is a nonprofit hospital.
New York-Presbyterian/Queens has an overall rating of 5 out of 5 stars in the official hospital quality ratings. Patients rate it 3 out of 5 stars in the patient survey. 3 death rate measures are better and 0 worse than the national rate.
Yes, New York-Presbyterian/Queens provides emergency services.
701 Medicare clinicians list New York-Presbyterian/Queens as a hospital they work at, most often in Internal Medicine, Physician Assistant, Diagnostic Radiology.
In 2024, New York-Presbyterian/Queens had 4,779 Medicare inpatient stays in 117 diagnosis groups. The most common was DRG 871 (septicemia or severe sepsis without mv >96 hours with mcc) with 896 stays; Medicare paid $20,187.41 per stay on average, compared with $15,524.21 across all hospitals.
In 2025, companies reported $346K in payments to New York-Presbyterian/Queens as a teaching hospital ($193K general and $153K for research) from 21 companies.